What 23 Analyst Ratings Have To Say About Eli Lilly and Co
What 23 Analyst Ratings Have To Say About Eli Lilly and Co
23位分析師評級對禮來公司有何看法
In the preceding three months, 23 analysts have released ratings for Eli Lilly and Co (NYSE:LLY), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，23位分析師發佈了禮來公司（紐約證券交易所代碼：LLY）的評級，提出了從看漲到看跌的各種觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級，簡要介紹了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Eli Lilly and Co, presenting an average target of $833.91, a high estimate of $1000.00, and a low estimate of $630.00. Marking an increase of 14.42%, the current average surpasses the previous average price target of $728.79.
在評估12個月目標股價時，分析師公佈了對禮來公司的見解，將平均目標股價定爲833.91美元，最高估計爲1000.00美元，低估值爲630.00美元。目前的平均價格上漲了14.42％，超過了之前的平均目標股價728.79美元。
Exploring Analyst Ratings: An In-Depth...
探索分析師評...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。